Model Answers Microbiology Written examinations 2007 - RCPA
Model Answers Microbiology Written examinations 2007 - RCPA
Model Answers Microbiology Written examinations 2007 - RCPA
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
For<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
This epidemic in gaining pace throughout Australia and ST93 in increasing<br />
rapidly and will probably overtake ST1 as the predominant strain<br />
PVL – give explanation<br />
PVL positive strains associated with furunculosis, and occasionally<br />
necrotising pneumonia, osteomyelitis (+septic thrombophebitis and PE in<br />
children), septicaemia. Fatal cases occur in young otherwise healthy children<br />
and adults.<br />
MRSA bacteraemia is a major issue as is S. aureus bacteraemia in general and<br />
is now being studied nationally (ANZCOSS). Thousands of cases are thought<br />
to occur annually with a mortality of approx. 30% (probably higher for<br />
MRSA)<br />
All of the above provides rationale for notification and intervention<br />
Intervention in CA-MRSA has occurred successfully in Denmark and is now<br />
being tried in WA. Contact tracing (household contacts) – increased hygiene,<br />
mupirocin, phisohex or chlorhexidine washes and follow up screening<br />
Establish baseline and benchmark<br />
Identify problem areas for intervention<br />
Evidence for successful HCA intervention strategies based on targeted<br />
screening and isolation is available and increased hand hygiene has also<br />
apparently been successful as an intervention in some settings<br />
Reduction of HCA MRSA has shown to reduce morbidity and mortality and to<br />
be cost effective in terms of overall health budget (through reducing<br />
morbidity, mortality and LOS)<br />
Establish population rates of CA MRSA<br />
Provide guidance to practitioners at a local level (empiric therapy etc.)<br />
Allow for community intervention<br />
Against<br />
<br />
<br />
<br />
<br />
Potential for stigmatisation of institutions based on MRSA rates<br />
Perception that intervention may be associated with increased costs<br />
Insufficient resources may be provided to labs or service providers to make the<br />
program work successfully<br />
Increased litigation may follow at the instigation of unscrupulous legal firms